|
|
|
|
|
|
|
|
|
|
|
30.03.26 - 23:18
|
Court Sanction of Scheme of Arrangement and Other Updates (GlobeNewswire EN)
|
|
|
30 March 2026 | SAINT HELIER, Jersey | On 8 September 2025 CoinShares International Limited (“CoinShares”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF) announced a joint merger plan with Vine Hill Capital Investment Corp (Nasdaq: VCIC) (“Vine Hill”) and Odysseus Holdings Limited (“Odysseus Holdings”), including a court-sanctioned scheme of arrangement under Article 125 of the Jersey Companies Law (“Scheme of Arrangement”) (such joint merger plan and the Scheme of Arrangement being together the “Transaction”). The Transaction once completed would in effect facilitate a change of listing venue for CoinShares shares from Nasdaq Stockholm to the Nasdaq Stock Market in the United States (“Nasdaq”). On 18 February 2026 CoinShares published a scheme circular in relation to the Scheme of Arrangement (the “Scheme Circular”)....
|
|
|
|
|
|
|
|
|
30.03.26 - 22:48
|
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights (Business Wire)
|
|
|
Received Regulatory Approval from Health Canada Supporting Initiation of Phase 2 DM199 Study in Early-onset Preeclampsia.
DM199 Preeclampsia Phase 2 Investigator-Sponsored Trial (IST) Part 1a Expansion Cohort Enrolling, Completion Expected in 1H 2026.
ReMEDy2 Phase 2/3 AIS Trial of DM199 Approaching 70% of Required Interim Enrollment; Interim Analysis planned 2H 2026.
$60 million in Cash, Cash Equivalents and Investments, Anticipated Runway through 2H 2027.
Conference Call and Webcast on March 31 at 8:00 AM ET / 7:00 AM CT.
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR), and acute ischemic stroke (AIS), today provided a business update and reported financial results for the year ended December 31, 2025. Management will host a conference call on Tuesday, March 31, 2026, at 8:00 AM Eastern Time / 7:00 AM Central Time to provide a business update a...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.03.26 - 21:42
|
The Law Offices of Frank L. Branson Again Receives Texas Super Lawyers Honors (Business Wire)
|
|
|
Firm founder Frank L. Branson marks 23rd year among honoreesDALLAS--(BUSINESS WIRE)--Five attorneys with the Law Offices of Frank L. Branson, led by the firm's founder, have been selected to the 2026 edition of Texas Super Lawyers for excellence in plaintiffs general personal injury cases.
Frank Branson, a member of the Super Lawyers list since its 2003 debut, is joined by Debbie D. Branson, John T. Burkhead, Tim Newsom and Wendell P. (Chip) Martens. This is the 18th appearance for Ms. Branson, the second for Mr. Burkhead, the 21st for Mr. Newsom, and the first for Mr. Martens.
The Branson firm is known nationwide for its work in complex personal injury and wrongful death cases. Mr. Branson is regularly listed among the top attorneys in Texas, and Ms. Branson is known for shaping trial preparation for the firm's high-stakes cases.
Mr. Burkhead has demonstrated success in connecting with jurors in catastrophic injury cases, and Mr. Newsom, who is board certified in personal injury trial law and civil tri...
|
|
|
|
|
|
|
|
|
|